تحميل...
Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime-and-boost vaccine regimen
Recombinant poxviruses expressing tumor-associated antigens (TAA) are currently being evaluated in clinical trials as an approach to treat various cancers. We have previously generated poxviral vectors expressing a TAA and a TRiad of COstimulatory Molecules (B7-1, ICAM-1, and LFA-3; TRICOM) as trans...
محفوظ في:
| المؤلفون الرئيسيون: | , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
2009
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3518379/ https://ncbi.nlm.nih.gov/pubmed/19450631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2009.05.017 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|